Please check your internet connection and try again.
# Arsil DX (Dextromethorphan/Chlorpheniramine)
## Overview
Arsil DX is a fixed-dose combination product containing dextromethorphan (an antitussive) and chlorpheniramine (a first-generation antihistamine). It is used for the symptomatic relief of cough and upper respiratory symptoms associated with the common cold or allergies.
## Primary Indications
Symptomatic relief of cough due to minor throat/bronchial irritation and management of upper respiratory symptoms such as sneezing, rhinorrhea, or watery eyes associated with common cold or allergic rhinitis.
## Adult Dosing
* **Standard Dose:** 10–20 mg (dextromethorphan) / 4 mg (chlorpheniramine) every 4 to 6 hours as needed.
* **Maximum Dose:** Do not exceed 120 mg of dextromethorphan and 24 mg of chlorpheniramine in a 24-hour period.
## Pediatric Dosing
* **Children 6 to 12 years:** 5–10 mg (dextromethorphan) / 2 mg (chlorpheniramine) every 4 to 6 hours as needed. Maximum: 60 mg dextromethorphan / 12 mg chlorpheniramine per 24 hours.
* **Children under 6 years:** Generally not recommended for over-the-counter use due to safety concerns and lack of efficacy data. Always consult a pediatrician.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No specific guidelines; use with caution. Reduced frequency is recommended to prevent accumulation of the antihistamine component, which may cause excessive sedation.
* **Geriatric Patients:** Start at the lower end of the dosing range due to increased risk of anticholinergic side effects (urinary retention, confusion, constipation).
## Contraindications
* Hypersensitivity to dextromethorphan or chlorpheniramine.
* Concurrent or recent (within 14 days) use of monoamine oxidase inhibitors (MAOIs) due to risk of serotonin syndrome.
* Acute asthma attack or severe lower respiratory tract conditions.
* Narrow-angle glaucoma.
## Adverse Effects
* **Common:** Drowsiness, dizziness, dry mouth, thickened respiratory secretions, blurred vision.
* **Serious:** Paradoxical CNS excitation (especially in children), urinary retention, tachycardia, and potential for abuse (dextromethorphan).
## Key Drug Interactions
* **MAOIs:** Risk of hypertensive crisis and serotonin syndrome.
* **CNS Depressants:** Alcohol, opioids, and benzodiazepines may significantly intensify sedation.
* **CYP2D6 Inhibitors:** Medications like fluoxetine or paroxetine may increase dextromethorphan levels.
* **Anticholinergics:** Additive effects (e.g., increased risk of dry mouth, urinary retention).
## Monitoring
* Monitor respiratory rate and character of cough.
* Monitor for signs of sedation or mental status changes.
* Assess for urinary retention, especially in patients with benign prostatic hyperplasia (BPH).
## Clinical Pearls
* **"DX" components:** The sedation caused by chlorpheniramine may mask the CNS-stimulating effects of dextromethorphan.
* **Self-Care:** Instruct patients that this medication treats symptoms, not the underlying infection. Encourage fluid intake to help thin secretions.
* **Labeling:** Always check the specific formulation concentration, as "DX" products vary significantly across different manufacturers and local protocols.
***
*Educational Disclaimer: This information is for educational purposes only. Clinical practice varies based on local protocols and patient-specific factors. Always verify current prescribing information, dosing, and contraindications via official package inserts or verified clinical databases (e.g., Lexicomp, UpToDate) before prescribing or administering medication.*
